| P50 | author | Harry B. Greenberg | Q55950186 |
| | Judith A. James | Q64978393 |
| | Jens Wrammert | Q66752613 |
| | Cornelia L. Dekker | Q89108153 |
| P2093 | author name string | Mark M Davis | |
| | Kenneth Smith | |
| | Tyson H Holmes | |
| | Xiao-Song He | |
| | Patrick C Wilson | |
| | Meghan Sullivan | |
| | Nai-Ying Zheng | |
| | David Furman | |
| | Sanae Sasaki | |
| | Carlos F Narvaez | |
| | Madhuri Nishtala | |
| P2860 | cites work | Rapid cloning of high-affinity human monoclonal antibodies against influenza virus | Q24644672 |
| | Structural Basis of Preexisting Immunity to the 2009 H1N1 Pandemic Influenza Virus | Q27660330 |
| | Predominant autoantibody production by early human B cell precursors | Q29619656 |
| | Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. | Q30371529 |
| | Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. | Q30380575 |
| | Immunity to pre-1950 H1N1 influenza viruses confers cross-protection against the pandemic swine-origin 2009 A (H1N1) influenza virus. | Q30390815 |
| | Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection | Q30398435 |
| | Influence of prior influenza vaccination on antibody and B-cell responses | Q33361605 |
| | Avidity as a determinant of the protective efficacy of human antibodies to pneumococcal capsular polysaccharides | Q33867137 |
| | Avidity, potency, and cross-reactivity of monoclonal antibodies to pneumococcal capsular polysaccharide serotype 6B | Q34005631 |
| | Immune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults: analysis of the variable heavy chain repertoire | Q34111761 |
| | Memory B cells from older people express normal levels of cyclooxygenase-2 and produce higher levels of IL-6 and IL-10 upon in vitro activation | Q34253264 |
| | The role of the antibody response in influenza virus infection. | Q34302556 |
| | Chemokines and the tissue-specific migration of lymphocytes | Q34515703 |
| | Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. | Q34649177 |
| | Mortality benefits of influenza vaccination in elderly people: an ongoing controversy | Q34693675 |
| | Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen | Q34953172 |
| | Plasma-cell homing | Q35549150 |
| | Intrinsic defects in B cell response to seasonal influenza vaccination in elderly humans | Q35571149 |
| | Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines | Q35629114 |
| | Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines. | Q35634295 |
| | Decreased expression of Kruppel-like factors in memory B cells induces the rapid response typical of secondary antibody responses. | Q35941417 |
| | Antibody response to influenza vaccination in the elderly: a quantitative review | Q36280602 |
| | Age-related defects in CD4 T cell cognate helper function lead to reductions in humoral responses | Q36399785 |
| | Vaccination in the elderly: an immunological perspective | Q37084886 |
| | Mechanisms for decreased function of B cells in aged mice and humans | Q37091607 |
| | B cells and aging: molecules and mechanisms | Q37398750 |
| | B-cell responses to vaccination at the extremes of age. | Q37400606 |
| | Aging affects human B cell responses | Q37841206 |
| | Plasmablast-derived polyclonal antibody response after influenza vaccination | Q40339871 |
| | An early humoral immune response in peripheral blood following parenteral inactivated influenza vaccination | Q41024287 |
| | Immunosenescence and germinal center reaction | Q41708767 |
| | Aging down-regulates the transcription factor E2A, activation-induced cytidine deaminase, and Ig class switch in human B cells | Q43648503 |
| | Intrinsic differences in the proliferation of naive and memory human B cells as a mechanism for enhanced secondary immune responses | Q44272089 |
| | Rectification of age-related impairment in Ig gene hypermutation during a memory response | Q44811123 |
| | Antibody diversity: one enzyme to rule them all. | Q45174128 |
| | Maintenance of serological memory by polyclonal activation of human memory B cells. | Q52008907 |
| | Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity | Q64131545 |
| | The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial | Q72821242 |
| | Effects of aging on proliferation and E47 transcription factor activity induced by different stimuli in murine splenic B cells | Q73315792 |
| | Immune function and vaccine responses in healthy advanced elderly patients | Q73977345 |
| | Systemic and mucosal immune responses in young children and adults after parenteral influenza vaccination | Q77524524 |
| | Correction of age-associated deficiency in germinal center response by immunization with immune complexes | Q80462487 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| | vaccine | Q134808 |
| | influenza vaccine | Q383260 |
| P304 | page(s) | 3109-3119 | |
| P577 | publication date | 2011-07-25 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies | |
| P478 | volume | 121 | |